[1] | Gauthier S.V., Khomyakov S.M. Organ donation and transplantation in the Russian Federation in 2017 // Bulletin of transplantology and artificial organs. -2018. -Vol. ХХ. -№2. - P.6-28. |
[2] | Mehta R.L. Renal-Replacement Therapy in the Critically Ill — Does Timing Matter? // N Engl J Med, 2016. -№375; 2: 175-176. |
[3] | Pikirenya A., Pirov B.S., Korotkov S.V., Kalachik O.V., Dzyadzko A.M., Rummo O.O. The formation and development of organ transplantation in the Republic of Belarus // Surgery. Eastern Europe. — 2016. — No. 2. — P. 98-106. |
[4] | Baymakhanov B.B., J.N. Kyzhyrov, M.M. Sakhipov, A.T. Chormanov, R.P. Ibragimov, Baidauletov J.Zh., Stamkulov F.T. Improving the technology of related kidney transplantation // Vestnik KazNMU, No. 1 - 2013.- P.205-209. |
[5] | Mandelbrot DA, Reese PP, Garg N, Thomas CP, Rodrigue JR, Schinstock C, Doshi M, Cooper M, Friedewald J, Naik AS, Kaul DR, Ison MG, Rocco MV, Verbesey J, Hladunewich MA, Ibrahim HN, Poggio ED KDOQI US Commentary on the 2017 KDIGO Clinical Practice Guideline on the Evaluation and Care of Living Kidney Donors // Am J Kidney Dis. 2020 Jan 20. pii: S0272-6386(19)31117-5. doi: 10.1053/j.ajkd.2019.10.005. |
[6] | Nazirov F.G., Ibadov R.A., Bakhriddinov F.Sh., Suyumov A.S., Matkarimov Z.T., Ibragimov S.Kh. Medical and social aspects of related kidney transplantation in the Republic of Uzbekistan // Medical Journal of Uzbekistan. -2017.-No. 6.- P.34-43. |
[7] | Nazyrova L.A., Khaibullina Z.R., Karimova N.M. The main factors of metabolic risk during kidney transplantation // Medical Journal of Uzbekistan, 2019. - №2.-P.41-45. |
[8] | Dobre M, Yang W, Chen J, Drawz P, Hamm LL, Horwitz E, Hostetter T, Jaar B, Lora CM, Nessel L, Ojo A, Scialla J, Steigerwalt S, Teal V, Wolf M, Rahman M, CRIC Investigators : Association of serum bicarbonate with risk of renal and cardiovascular outcomes in CKD: A report from the Chronic Renal Insufficiency Cohort (CRIC) study // Am J Kidney Dis 2013. |
[9] | Wu DY, Shinaberger CS, Regidor DL, McAllister CJ, Kopple JD, Kalantar-Zadeh K: Association between serum bicarbonate and death in hemodialysis patients: Is it better to be acidotic or alkalotic? // Clin J Am SocNephrol. -2006. -1: 70–78. |
[10] | Wiegand A, Ritter A, Graf N, Arampatzis S, Sidler D, Hadaya K, Müller TF, Wagner CA, Wüthrich RP, Mohebbi N. Preservation of kidney function in kidney transplant recipients by alkali therapy (Preserve-Transplant Study): rationale and study protocol // BMC Nephrol., 2018 Jul 13; 19(1): 177. doi: 10.1186/s12882-018-0956-8. |
[11] | Yaqoob MM: Acidosis and progression of chronic kidney disease //CurrOpinNephrol Hypertens. -2010. -№ 19: 489–492. |
[12] | Menon V, Tighiouart H, Vaughn NS, Beck GJ, Kusek JW, Collins AJ, Greene T, Sarnak MJ: Serum bicarbonate and long-term outcomes in CKD // Am J Kidney Dis 2010.-56: 907–914. |
[13] | Navaneethan SD, Schold JD, Arrigain S, Jolly SE, Wehbe E, Raina R, Simon JF, Srinivas TR, Jain A, Schreiber MJ, Jr, Nally JV, Jr: Serum bicarbonate and mortality in stage 3 and stage 4 chronic kidney disease // Clin J Am SocNephrol, 2011. -6: 2395–2402. |
[14] | Eustace JA, Astor B, Muntner PM, Ikizler TA, Coresh J: Prevalence of acidosis and inflammation and their association with low serum albumin in chronic kidney disease // Kidney Int, 2004.-65: 1031–1040. |
[15] | Kidney Disease Improving Global Outcomes Work Group : KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease // Kidney IntSuppl 2013.- 3: 1–150. |
[16] | Capusa C., Stefan G., Stancu S., Lipan M., Tsur L-D, Mircescu G. Metabolic acidosis of chronic kidney disease and subclinical cardiovascular disease markersFriend or foe?// Medicine. - 2017.-№96.-Р.47-56. |
[17] | Djamali A., Singh T., Melamed M.L. Stein J.H., Aziz F., Parajuli S. Metabolic Acidosis 1 Year Following Kidney Transplantation and Subsequent Cardiovascular Events and Mortality: An Observational Cohort Study //Am J Kidney Dis. -2019; pii: S0272-6386 (19) 30002-2. doi: 10.1053/j.ajkd.2018.12.023. |
[18] | Park S., Kang E., Park S., Kim Y.C. Metabolic acidosis and long term clinical outcomes in kidney transplantat recipients // J Am Soc Nephrol, 2017. -28: 1886–1897,. doi: https: //doi.org/ 10.1681/ASN.2016070793. |
[19] | Wesson DE, Simoni J, Broglio K, Sheather S: Acid retention accompanies reduced GFR in humans and increases plasma levels of endothelin and aldosterone // Am J Physiol Renal Physiol, 2011.- 300: F830–F837. |
[20] | Sinyutin A.A., Vatazin A.V., Zulkarnaev A.B., Cantaria R.O., Krstic M. The use of plasmapheresis for the correction of functional disorders and microcirculation disorders of the renal allograft in the early postoperative period // Nephrology, 2013. - Volume 17. No. 4.-P.83-88. |
[21] | Recio-Mayoral A, Banerjee D, Streather C, Kaski JC: Endothelial dysfunction, inflammation and atherosclerosis in chronic kidney disease — a cross-sectional study of predialysis, dialysis and kidney-transplantation patients // Atherosclerosis, 2011.- 216: 446–451. |
[22] | Reine TM, Lanzalaco F, Kristiansen O, Enget AR, Satchell S, Jenssen TG, Kolset SO. Matrix metalloproteinase-9 mediated shedding of syndecan-4 in glomerular endothelial cells //Microcirculation, 2019 Jan 31: e12534. doi: 10.1111/micc.12534. |
[23] | Nath KA, Hostetter MK, Hostetter TH: Increased ammoniagenesis as a determinant of progressive renal injury // Am J Kidney Dis, 1991. -17: 654–657. |
[24] | Vatazin A.V., Sinyutin A.A., Zulkarnaev A.B., Patyukov K.A., Kantaria R.O., Krstich M. Metabolic disorders in the intra- and postoperative period during kidney transplantation // Clinical Nephrology, 2014; 2: 56-60. |
[25] | Tepaev R.F., Lastovka V.A., Pytal A.V., Savluk A.V. Metabolic acidosis: diagnostics and treatment // Pediatric pharmacology. -2016. -№13 (4). -P. 385-389. |
[26] | Berend K. Diagnostic Use of Base Excess in Acid–Base Disorders //N Engl J Med, 2018; 378: 1419-28. DOI: 10.1056/NEJMra1711860. |
[27] | Khaybullina Z.R. Synthetic antioxidants and its effects in ultra low concentrations, probability of cardio protection by membrane stabilization (memories of my teachers – academician U.K. Ibragimov and E.B.Burlakova is denoted) //J Cardiol&CardiovascTher 2017; 4(5): 555647. DOI: 10.19080/JOCCT.2017.04.555647.JOCCT.MS.ID.555647(2017). |
[28] | Crépin T, Legendre M , Carron C, Vachey C, Courivaud C, Rebibou JM, Ferrand C, Laheurte C, Vauchy C, Gaiffe E, Saas P, Ducloux D , Bamoulid J. Uraemia-induced immune senescence and clinical outcomes in chronic kidney disease patients //Nephrol Dial Transplant, 2018 Sep 6. doi: 10.1093/ndt/gfy276. |
[29] | Chen A, Dong L, Leffler NR, Asch AS, Witte ON, Yang LV: Activation of GPR4 by acidosis increases endothelial cell adhesion through the cAMP/Epac pathway // PLoSONE, 2011. -6: e27586. |
[30] | Suslov V.V., Gritsenko S.N. Features of anesthesia and intensive care for kidney allotransplantation // Ukrainian Journal of Extreme Medicine named after G.O. Mozhaev. Vol. 13, No. 2, 2012. -P.34-39. |
[31] | Abramowitz MK, Hostetter TH, Melamed ML: Lower serum bicarbonate and a higher anion gap are associated with lower cardiorespiratory fitness in young adults // Kidney Int, 2012.- 81: 1033–1042. |
[32] | Dobre M, Rahman Mahboob, and Thomas H. Hostetter. Current Status of Bicarbonate in CKD //J Am SocNephrol., 2015. -Mar; 26(3): 515–523. |
[33] | Piotti G, Gandolfini I, Palmisano A and Maggiore U. Metabolic risk profile in kidney transplant candidates and recipients // Nephrol Dial Transplant, 2018. -№ 1–13 doi: 10.1093/ndt/gfy151. |
[34] | Skiba K, Gojowy D, Szotowska M, Bartmańska M, Kolonko A, Cierpka L, Więcek A, Adamczak M. Metabolic acidosis in patients after kidney transplantation //Pol Arch Intern Med., 2018 Sep 12. doi: 10.20452/pamw.4329. |